Spotlight
Specialty
Partners
CME/CE
Monitoring Patients on Therapy for Recurrent Endometrial Cancer
Kimberly Halla, NP, describes the standards for monitoring patients on therapy for recurrent endometrial cancer, including how often patients are seen in-person.
EP: 1.Patient Profile Presentation: A 76-Year-Old Woman With Advanced Endometrial Cancer
EP: 2.Fertility and Other Treatment Considerations for Patients With Advanced Endometrial Cancer
EP: 3.Currently Available Treatment Modalities in Endometrial Cancer
EP: 4.First-Line Treatments for Patients With Advanced Endometrial Cancer Who Are Unfit for Surgery
EP: 5.Common Adverse Events Seen With Chemotherapy for Advanced Endometrial Cancer
EP: 6.Efficacy of Chemotherapy in Patients with Advanced Endometrial Cancer
EP: 7.Treatment Options for Patients with Recurrent Endometrial Cancer
EP: 8.Educating Patients With Endometrial Cancer on Treatment-Related Adverse Events
Now Viewing
EP: 9.Monitoring Patients on Therapy for Recurrent Endometrial Cancer
EP: 10.Adverse Events Seen With Combination Lenvatinib and Pembrolizumab for Recurrent Endometrial Cancer
EP: 11.Proactive Adverse Effect Management for Patients on Therapy for Endometrial Cancer
EP: 12.Discussing Dose Reductions and Interruptions with Patients on Therapy for Endometrial Cancer
EP: 13.Greatest Unmet Needs for Patients with Endometrial Cancer
EP: 14.Advice for New Nurse Practitioners Working With Patients With Endometrial Cancer
Related Videos
Related Content
